ALS and other motor neuron diseases.

Area of Science:

• Neurology
• Genetics
• Pathophysiology

Background:

• Motor neuron diseases, particularly Amyotrophic Lateral Sclerosis (ALS), affect anterior horn cells controlling voluntary movement.
• Diagnosis and evaluation of ALS and other motor neuron diseases present challenges for clinicians.
• Understanding the pathophysiology of these diseases is crucial for effective management.

Purpose of the Study:

• To review the common motor neuron disease, ALS, including its diagnosis, evaluation, and pathophysiology.
• To discuss new genetic underpinnings and recent discoveries in ALS etiology.
• To cover other motor neuron diseases, differentiate them from ALS, and discuss their pathophysiology.

Main Methods:

• Literature review of current understanding of ALS and other motor neuron diseases.
• Analysis of recent findings on genetic associations and protein synthesis pathology in ALS.
• Examination of diagnostic criteria and differentiation between various motor neuron diseases.

Main Results:

• Recent genetic discoveries explain a substantial percentage of familial and sporadic ALS cases.
• TAR DNA binding protein 43 kDa (TDP-43) is implicated in frontotemporal dementia and some ALS cases.
• Cognitive involvement and protein synthesis pathology are key areas of ongoing research in ALS.

Conclusions:

• Anterior horn cell damage profoundly impacts motor, respiratory, speech, and swallowing functions.
• Neurologists play a critical role in diagnosing, managing, and coordinating care for patients with motor neuron diseases.
• Accurate identification and evaluation of motor neuron diseases are essential for patient care and treatment planning.